To improve the existing techniques, it is necessary to deepen the causes of their limitations or shortcomings, for whose understanding we focus on the characteristics of the solid phases manufactured for the capture of IgE and the context of the peculiarities of drug allergy. Here, IGHE is linked to allergic disease.